| abstract |
The present invention relates to aminochromans, aminothiochromans and amino-1,2,3,4-tetrahydroquinoline derivatives of formula (I), or physiologically acceptable salts thereof. The present invention relates to pharmaceutical compositions comprising such aminochromans, aminothiochromans and amino-1,2,3,4-tetrahydroquinoline derivatives, as well as such aminochromans, aminothiochromans and amino-1,2, It relates to the use of 3,4-tetrahydroquinoline derivatives for therapeutic purposes. Aminochroman, aminothiochroman and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors. |